Contents
Download PDF
pdf Download XML
327 Views
140 Downloads
Share this article
Review Article | Volume 14 Issue:1 (Jan-Feb, 2024) | Pages 267 - 272
Looking Forward Vericiguat in Heart Failure - A Systematic Review
1
Professor and Head, Department of Medicine, MIMER Medical College, Talegaon Dabhade, Pune.
Under a Creative Commons license
Open Access
DOI : 10.5083/ejcm
Received
Nov. 15, 2023
Revised
Dec. 11, 2023
Accepted
Jan. 3, 2024
Published
Jan. 20, 2024
Abstract

Background:  Despite recent advances in heart failure (HF) management, mortality and morbidity remain high in patients with heart failure with reduced and preserved ejection fraction. HF is characterized by endothelial dysfunction, inflammation, and increased oxidative stress that results due to a reduction in the activity of the nitric oxide-soluble guanylate cyclase-cyclic guanosine monophosphate (NO-sGC-cGMP) signaling pathway. All these factors contribute to direct damage at the myocardial, vascular, and renal levels. At a fundamental level, it is known that this cardioprotective pathway of NO-sGC-cGMP is impaired in heart failure patients. Materials and Methods: Vericiguat is a soluble guanylate cyclase stimulator approved by various global regulatory bodies in January 2021 and recommended in recently updated clinical practice guidelines to reduce morbidity and mortality in patients with worsening chronic heart failure (HF) with reduced ejection fraction (HFrEF). It is a novel, orally used, small molecule, and direct stimulator of the soluble guanylate cyclase. It restores the deficiency in this signaling pathway, through stimulation and activation of sGC, aiming to increase cGMP levels, with a reduction in HF-related oxidative stress and endothelial dysfunction. For the present systematic review a Boolean search was carried out in Pubmed, Google Scholar and Embase. Conclusion: Overall, four main clinical trials have been carried out for vericiguat namely the SOCRATES-REDUCED, SOCRATES - PRESERVED, VICTORIA, and VITALITY. Vericiguat resulted in reduced CV death and HF hospitalization in patients with HFrEF and a recent episode of cardiac decompensation.

Keywords
Recommended Articles
Research Article
Glycemic Dysregulation in Pregnancy and Its Impact on Neonatal Glucose Homeostasis and Birth Weight: A Clinical Correlation Study
...
Published: 31/12/2024
Download PDF
Research Article
Impact of Delivery Method on Neonatal Gut Microbiota Composition: A Prospective Cohort Study in South Indian Infants
...
Published: 28/10/2024
Download PDF
Research Article
A Comparitive Study of Recombinant Erythropoetin Injectables Versus the Oral Formulation of Desidustat in Treating Patients of the Anemia of Chronic Kidney Disease
...
Published: 22/06/2025
Download PDF
Research Article
Incidence of Postdural Puncture Headache with and Without Re-Insertion of Stylet Before Removing Spinal Needle in Patients Undergoing LSCS Under Spinal Anesthesia with 26G quincke Needle
...
Published: 21/06/2025
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.